edaravone has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone is a mitochondrially targeted drug with a suggested capability to modify the course of diverse neurological diseases." | 1.91 | Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1. ( Benediktova, S; Cendelin, J; Jedlicka, J; Jelinkova, D; Kapl, S; Kuncova, J; Purkartova, Z; Sucha, M; Tichanek, F; Tuma, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sucha, M | 1 |
| Benediktova, S | 1 |
| Tichanek, F | 1 |
| Jedlicka, J | 1 |
| Kapl, S | 1 |
| Jelinkova, D | 1 |
| Purkartova, Z | 1 |
| Tuma, J | 1 |
| Kuncova, J | 1 |
| Cendelin, J | 1 |
1 other study available for edaravone and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1.
Topics: Animals; Bayes Theorem; Cerebellum; Cognitive Dysfunction; Disease Models, Animal; Edaravone; Mice; | 2023 |